Ubs Group Ag Tela Bio, Inc. Transaction History

Ubs Group Ag

$528 Billion
Q1 2025

A detailed history of Ubs Group Ag transactions in Tela Bio, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 330,683 shares of TELA stock, worth $658,059. This represents 0.0% of its overall portfolio holdings.

Number of Shares

330,683

Previous 767,830 56.93%

Holding current value

$658,059

Previous $2.32 Million 82.61%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$1.22 - $2.91 $533,319 - $1.27 Million	-437,147 Reduced 56.93%	330,683 $403,000
Q4 2024 Feb 14, 2025	BUY	$2.38 - $3.14 $1.83 Million - $2.41 Million	767,830 New	767,830 $2.32 Million
Q2 2024 Aug 13, 2024	SELL	$4.39 - $6.36 $59,901 - $86,782	-13,645 Reduced 75.76%	4,367 $20,000
Q1 2024 May 13, 2024	SELL	$5.3 - $7.61 $3.56 Million - $5.11 Million	-670,910 Reduced 97.39%	18,012 $102,000
Q4 2023 Feb 09, 2024	BUY	$4.5 - $7.51 $3.05 Million - $5.09 Million	677,933 Added 6169.2%	688,922 $4.56 Million
Q3 2023 Nov 09, 2023	BUY	$7.85 - $10.68 $14,043 - $19,106	1,789 Added 19.45%	10,989 $87,000
Q2 2023 Aug 11, 2023	BUY	$9.23 - $11.23 $76,295 - $92,827	8,266 Added 885.01%	9,200 $93,000
Q1 2023 May 12, 2023	SELL	$9.41 - $12.03 $23,308 - $29,798	-2,477 Reduced 72.62%	934 $9,000
Q4 2022 Feb 08, 2023	BUY	$6.5 - $11.5 $858 - $1,518	132 Added 4.03%	3,411 $39,000
Q3 2022 Nov 10, 2022	BUY	$7.36 - $9.15 $8,787 - $10,925	1,194 Added 57.27%	3,279 $28,000
Q2 2022 Aug 10, 2022	BUY	$5.54 - $11.49 $5,279 - $10,949	953 Added 84.19%	2,085 $15,000
Q1 2022 May 16, 2022	SELL	$11.35 - $13.7 $132,987 - $160,522	-11,717 Reduced 91.19%	1,132 $13,000
Q4 2021 Feb 14, 2022	SELL	$11.95 - $13.34 $8,878 - $9,911	-743 Reduced 5.47%	12,849 $164,000
Q3 2021 Nov 15, 2021	BUY	$12.2 - $15.93 $2,879 - $3,759	236 Added 1.77%	13,592 $186,000
Q2 2021 Aug 13, 2021	SELL	$11.7 - $16.11 $16,181 - $22,280	-1,383 Reduced 9.38%	13,356 $215,000
Q1 2021 May 12, 2021	BUY	$12.84 - $17.26 $4,070 - $5,471	317 Added 2.2%	14,739 $220,000
Q4 2020 Feb 11, 2021	SELL	$14.61 - $17.59 $43,333 - $52,171	-2,966 Reduced 17.06%	14,422 $217,000
Q3 2020 Nov 12, 2020	SELL	$11.64 - $16.86 $9,940 - $14,398	-854 Reduced 4.68%	17,388 $288,000
Q2 2020 Jul 31, 2020	BUY	$7.75 - $22.61 $15,972 - $46,599	2,061 Added 12.74%	18,242 $236,000
Q4 2019 Feb 14, 2020	BUY	$11.26 - $13.8 $182,198 - $223,297	16,181 New	16,181 $210,000

Others Institutions Holding TELA

# of Institutions

Shares Held

24.9M

Call Options Held

775K

Put Options Held

300

View Full List

About TELA Bio, Inc.

Ticker TELA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 19,157,600
Market Cap $38.1M
Description
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...

More about TELA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account